Ovarian cancer: promising results from a combination of immunotherapy
A new immunotherapeutic strategy, combining ipilimumab and nivolumab, gives very promising results in ovarian cancer in the relapse phase.The addition ...
Read moreTag: ipilimumab
Melanoma: immunotherapy limits recurrence and improves survival
The search for treatments against virulent forms of melanoma seems promising. Three recent studies highlight the benefits of immunotherapy.Researchers are ...
Read more
Advanced melanoma: cancer drug ipilimumab can survive for 10 years
© iStockA survey made public in Amsterdam at the European Cancer Congress revealed these encouraging results. They were established following ...
Read moreThe cost of a living
The life of a woman or a man who is still young now has a price: 200,000 euros, that of ...
Read more